162 research outputs found
Women in the Miners' Strike, 1984-5. An essay to accompany the exhibition at the National Coal Mining Museum for England
Recommended from our members
The synchrotron radiation angiography program at the national synchrotron light source
The National Synchrotron Light Source (NSLS) angiography program is under development. The program is a collaboration between the Stanford University Angiography Project and the NSLS. A 180 m/sup 2/ clinical facility has been built. A beam line is being constructed to utilize a superconducting wiggler radiation source. Projected start-up date for the NSLS program is Summer 1988
Diffraction enhanced X-ray imaging
Abstract. Diffraction enhanced imaging is a new x-ray radiographic imaging modality using monochromatic x-rays from a synchrotron which produces images of thick absorbing objects that are almost completely free of scatter. They show dramatically improved contrast over standard imaging applied to the same phantom. The contrast is based not only on attenuation but also the refraction and diffraction properties of the sample. This imaging method may improve image quality for medical applications, industrial radiography for non-destructive testing and x-ray computed tomography
Dynamics of liquid 4He in Vycor
We have measured the dynamic structure factor of liquid 4He in Vycor using
neutron inelastic scattering. Well-defined phonon-roton (p-r) excitations are
observed in the superfluid phase for all wave vectors 0.3 < Q < 2.15. The p-r
energies and lifetimes at low temperature (T = 0.5 K) and their temperature
dependence are the same as in bulk liquid 4He. However, the weight of the
single p-r component does not scale with the superfluid fraction (SF) as it
does in the bulk. In particular, we observe a p-r excitation between T_c =
1.952 K, where SF = 0, and T_(lambda)=2.172 K of the bulk. This suggests, if
the p-r excitation intensity scales with the Bose condensate, that there is a
separation of the Bose-Einstein condensation temperature and the superfluid
transition temperature T_c of 4He in Vycor. We also observe a two-dimensional
layer mode near the roton wave vector. Its dispersion is consistent with
specific heat and SF measurements and with layer modes observed on graphite
surfaces.Comment: 3 pages, 4 figure
Uptake Rate of Cationic Mitochondrial Inhibitor MKT-077 Determines Cellular Oxygen Consumption Change in Carcinoma Cells
<div><h3>Objective</h3><p>Since tumor radiation response is oxygen-dependent, radiosensitivity can be enhanced by increasing tumor oxygenation. Theoretically, inhibiting cellular oxygen consumption is the most efficient way to increase oxygen levels. The cationic, rhodacyanine dye-analog MKT-077 inhibits mitochondrial respiration and could be an effective metabolic inhibitor. However, the relationship between cellular MKT-077 uptake and metabolic inhibition is unknown. We hypothesized that rat and human mammary carcinoma cells would take up MKT-077, causing a decrease in oxygen metabolism related to drug uptake.</p> <h3>Methods</h3><p>R3230Ac rat breast adenocarcinoma cells were exposed to MKT-077. Cellular MKT-077 concentration was quantified using spectroscopy, and oxygen consumption was measured using polarographic electrodes. MKT-077 uptake kinetics were modeled by accounting for uptake due to both the concentration and potential gradients across the plasma and mitochondrial membranes. These kinetic parameters were used to model the relationship between MKT-077 uptake and metabolic inhibition. MKT-077-induced changes in oxygen consumption were also characterized in MDA-MB231 human breast carcinoma cells.</p> <h3>Results</h3><p>Cells took up MKT-077 with a time constant of ∼1 hr, and modeling showed that over 90% of intracellular MKT-077 was bound or sequestered, likely by the mitochondria. The uptake resulted in a rapid decrease in oxygen consumption, with a time constant of ∼30 minutes. Surprisingly the change in oxygen consumption was proportional to uptake rate, not cellular concentration. MKT-077 proved a potent metabolic inhibitor, with dose-dependent decreases of 45–73% (p = 0.003).</p> <h3>Conclusions</h3><p>MKT-077 caused an uptake rate-dependent decrease in cellular metabolism, suggesting potential efficacy for increasing tumor oxygen levels and radiosensitivity <em>in vivo</em>.</p> </div
Recommended from our members
CT imaging of small animals using monochromatized synchrotron x rays
Rats and chicken embryos were imaged in vivo with a prototype Multiple Energy Computed Tomography (MECT) system using monochromatized x rays from the X17 superconducting wiggler at the National Synchrotron Light Source. The CT configuration coated of a horizontal low-divergence, fan-shaped beam, 70 mm wide and 0.5 mm high, and a subject rotating about a vertical aids. A linear-array high-purity Ge detector with 140 elements, each 0.5 mm wide and 6 mm thick, was used with a data acquisition system that provides a linear response over almost six orders of magnitude of detector current. The dual photon absorptiometry (DPA) algorithm was applied to images of the rat head acquired at 20 and 45 keV to obtain two new images, one representing the low-Z, and the other the intermediate-Z clement group. The results indicate that the contrast resolution and the quantification accuracy of the images improve stepwise; first, with the monochromatic beam and, second, the DPA method. The system is a prototype for a brain scanner
Long-term exposure to hypoxia inhibits tumor progression of lung cancer in rats and mice
<p>Abstract</p> <p>Background</p> <p>Hypoxia has been identified as a major negative factor for tumor progression in clinical observations and in animal studies. However, the precise role of hypoxia in tumor progression has not been fully explained. In this study, we extensively investigated the effect of long-term exposure to hypoxia on tumor progression <it>in vivo.</it></p> <p>Methods</p> <p>Rats bearing transplanted tumors consisting of A549 human lung cancer cells (lung cancer tumor) were exposed to hypoxia for different durations and different levels of oxygen. The tumor growth and metastasis were evaluated. We also treated A549 lung cancer cells (A549 cells) with chronic hypoxia and then implanted the hypoxia-pretreated cancer cells into mice. The effect of exposure to hypoxia on metastasis of Lewis lung carcinoma in mice was also investigated.</p> <p>Results</p> <p>We found that long-term exposure to hypoxia a) significantly inhibited lung cancer tumor growth in xenograft and orthotopic models in rats, b) significantly reduced lymphatic metastasis of the lung cancer in rats and decreased lung metastasis of Lewis lung carcinoma in mice, c) reduced lung cancer cell proliferation and cell cycle progression <it>in vitro</it>, d) decreased growth of the tumors from hypoxia-pretreated A549 cells, e) decreased Na<sup>+</sup>-K<sup>+ </sup>ATPase α1 expression in hypoxic lung cancer tumors, and f) increased expression of hypoxia inducible factors (HIF1α and HIF2α) but decreased microvessel density in the lung cancer tumors. In contrast to lung cancer, the growth of tumor from HCT116 human colon cancer cells (colon cancer tumor) was a) significantly enhanced in the same hypoxia conditions, accompanied by b) no significant change in expression of Na<sup>+</sup>-K<sup>+ </sup>ATPase α1, c) increased HIF1α expression (no HIF2α was detected) and d) increased microvessel density in the tumor tissues.</p> <p>Conclusions</p> <p>This study demonstrated that long-term exposure to hypoxia repressed tumor progression of the lung cancer from A549 cells and that decreased expression of Na<sup>+</sup>-K<sup>+ </sup>ATPase was involved in hypoxic inhibition of tumor progression. The results from this study provide new insights into the role of hypoxia in tumor progression and therapeutic strategies for cancer treatment.</p
Blood Transfusion Requirements for Patients With Sarcomas Undergoing Combined Radio- and Chemotherapy
Patients with bony and soft tissue sarcomas may require intensive treatment with chemotherapy and radiotherapy,
which often leads to a fall in haemoglobin levels, requiring blood transfusion. There may be advantages in predicting
which patients will require transfusion, partly because anaemia and hypoxia may worsen the response of tumours to
chemotherapy and radiotherapy. Between 1997 and 2003, a total of 26 patients who received intensive treatment with
curative intent were identified. Transfusions were given to maintain the haemoglobin at 10g/dl or above during
chemotherapy, and at 12 g/dl or above during radiotherapy. Eighteen (69%) required a transfusion, the majority
as a result of both the chemotherapy and RT criteria. There were 78 transfusion episodes, and 181 units of blood given.
In the 18 patients who required transfusion, the average number of units was 10.1, but seven patients required more
blood than this. The most significant factor influencing blood transfusion was choice of intensive chemotherapy.
Intensive chemotherapy and presenting Hb less than 11.6 g/dl identified 13 out of 18 patients who needed transfusion.
Adding a drop in haemoglobin of greater than 1.7 g/dl after one cycle of chemotherapy identified 16 out of 18 patients
who required transfusion. The seven patients who had heavy transfusion requirements were identified by age 32 or less,
intensive chemotherapy and a presenting Hb of 12 g/dl or less. Erythropoietin might be a useful alternative to transfusion
in selected patient groups, especially those with heavy transfusion requirements
- …